Skip to main content

ISB Expands Use of Lumera Technology to Cover Biomarker Detection Technology

NEW YORK (GenomeWeb News) — Lumera has expanded its agreement with the Institute for Systems Biology to focus on detection methods for a cancer biomarker array, the Bothell, Wash.-based company said today.
 
The expanded agreement builds on a February 2005 pact in whic ISB agreed to test Lumera's ProteomicProcessor system.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.